Millions of Americans can now look forward to a better time traveling, with the US Food and Drug Administration (FDA) ...

The FDA approved Vanda’s drug Nereus to prevent motion-induced vomiting, opening a potential path into treating nausea linked ...

Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are ...

Vanda Pharmaceuticals has received FDA approval for Nereus (tradipitant), an oral NK-1 receptor antagonist developed to prevent motion-induced vomiting. The approval makes Nereus the first new ...

Vanda also sells sleep disorder drug Hetlioz, which reached the market in 2014, and relapsing multiple sclerosis treatment ...

The FDA has approved tradipitant (Nereus), an oral NK-1 receptor antagonist, for preventing motion-induced vomiting in adults ...

If you’re prone to motion sickness, you know the feeling of panic that comes with the onset of symptoms like nausea, dizziness and an upset stomach. Motion sickness manifests in different ways and ...

You’ve finally made it on vacation, whether it’s a scenic winding mountain road trip, a boating excursion or a plane ride to the beach. Just as you are starting to relax and enjoy yourself, a wave of ...

Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. If you’re prone to motion sickness, you know the feeling of panic ...

NEW YORK, July 26, 2024 /PRNewswire/ -- The global motion sickness drugs market size is estimated to grow by USD 139.5 million from 2024-2028, according to Technavio. The market is estimated to grow ...

Prior to holiday trips by car, plane, train or boat, I find many parents traveling to my office with lots of questions about motion sickness with the hope that this problem can be prevented before it ...